lazertinib

1 Drug classified under this active ingredient

Kinase Inhibitor. lazertinib 80 mg, 240 mg.
FC Tabs.:60 X 80mg/ 14/28/30 X 240 mg
 Recomm. dose:240 mg orally once/d in combin. with amivantamab until dis. progress. or unacceptable tox.Ffirst-line tmt. of adults with locally adv. or metast. non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitut. mutat., as detected by an approved test, in combin. with amivantamab
C/I: Hypersens.